- call +1-201-465-4211
- email sales@mrinsights.biz
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.
Scope of the Report:
The Global Advanced Drug Delivery Market is poised to grow at a CAGR of around 7.8% over the next decade to reach approximately $340 billion by 2025. Some of the prominent trends that the market is witnessing include growing focus on unmet medical requirements, increasing demand for generic drugs and biosimilars, rising familiarities of chronic diseases and recent technological developments of advanced drug delivery.
Based on technology, the market is categorized into polymeric drug delivery, implants & IUD's, sustained release, targeted drug delivery and prodrugs. By polymeric drug delivery, the market is further divided into nebulizers, metered dose inhalers and dry powder inhalers.
By end user, the market is segregated into hospitals, diagnostic centers, ambulatory surgical centers/clinics, home care settings and other end users.
The worldwide market for Advanced Drug Delivery is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Advanced Drug Delivery in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Merck & Co
Antares Pharma
F. Hoffmann-La Roche
Novartis
Bayer
Sanofi
Glaxosmithkline
3M
Pfizer
Johnson & Johnson
Abbott Laboratories
Allergan
Baxter International
Mylan Pharmaceutical
Roche Holding
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Polymeric Drug Delivery
Implants & IUD's
Sustained Release
Targeted Drug Delivery
Prodrugs
Market Segment by Applications, can be divided into
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers/Clinics
Home Care Settings
Other End Users
There are 15 Chapters to deeply display the global Advanced Drug Delivery market.
Chapter 1, to describe Advanced Drug Delivery Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Advanced Drug Delivery, with sales, revenue, and price of Advanced Drug Delivery, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Advanced Drug Delivery, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Advanced Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Advanced Drug Delivery sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Advanced Drug Delivery Introduction
1.2 Market Analysis by Type
1.2.1 Polymeric Drug Delivery
1.2.2 Implants & IUD's
1.2.3 Sustained Release
1.2.4 Targeted Drug Delivery
1.2.5 Prodrugs
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Diagnostic Centers
1.3.3 Ambulatory Surgical Centers/Clinics
1.3.4 Home Care Settings
1.3.5 Other End Users
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck & Co
2.1.1 Business Overview
2.1.2 Advanced Drug Delivery Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck & Co Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Antares Pharma
2.2.1 Business Overview
2.2.2 Advanced Drug Delivery Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Antares Pharma Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann-La Roche
2.3.1 Business Overview
2.3.2 Advanced Drug Delivery Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Advanced Drug Delivery Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bayer
2.5.1 Business Overview
2.5.2 Advanced Drug Delivery Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bayer Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Advanced Drug Delivery Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Glaxosmithkline
2.7.1 Business Overview
2.7.2 Advanced Drug Delivery Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Glaxosmithkline Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 3M
2.8.1 Business Overview
2.8.2 Advanced Drug Delivery Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 3M Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Advanced Drug Delivery Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.2 Advanced Drug Delivery Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson & Johnson Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Abbott Laboratories
2.11.1 Business Overview
2.11.2 Advanced Drug Delivery Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Abbott Laboratories Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Allergan
2.12.1 Business Overview
2.12.2 Advanced Drug Delivery Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Allergan Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Baxter International
2.13.1 Business Overview
2.13.2 Advanced Drug Delivery Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Baxter International Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Mylan Pharmaceutical
2.14.1 Business Overview
2.14.2 Advanced Drug Delivery Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Mylan Pharmaceutical Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Roche Holding
2.15.1 Business Overview
2.15.2 Advanced Drug Delivery Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Roche Holding Advanced Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Advanced Drug Delivery Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Advanced Drug Delivery Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Advanced Drug Delivery Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Advanced Drug Delivery Manufacturer Market Share in 2017
3.3.2 Top 6 Advanced Drug Delivery Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Advanced Drug Delivery Market Analysis by Regions
4.1 Global Advanced Drug Delivery Sales, Revenue and Market Share by Regions
4.1.1 Global Advanced Drug Delivery Sales and Market Share by Regions (2013-2018)
4.1.2 Global Advanced Drug Delivery Revenue and Market Share by Regions (2013-2018)
4.2 North America Advanced Drug Delivery Sales and Growth Rate (2013-2018)
4.3 Europe Advanced Drug Delivery Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Advanced Drug Delivery Sales and Growth Rate (2013-2018)
4.5 South America Advanced Drug Delivery Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Advanced Drug Delivery Sales and Growth Rate (2013-2018)
5 North America Advanced Drug Delivery by Countries
5.1 North America Advanced Drug Delivery Sales, Revenue and Market Share by Countries
5.1.1 North America Advanced Drug Delivery Sales and Market Share by Countries (2013-2018)
5.1.2 North America Advanced Drug Delivery Revenue and Market Share by Countries (2013-2018)
5.2 United States Advanced Drug Delivery Sales and Growth Rate (2013-2018)
5.3 Canada Advanced Drug Delivery Sales and Growth Rate (2013-2018)
5.4 Mexico Advanced Drug Delivery Sales and Growth Rate (2013-2018)
6 Europe Advanced Drug Delivery by Countries
6.1 Europe Advanced Drug Delivery Sales, Revenue and Market Share by Countries
6.1.1 Europe Advanced Drug Delivery Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Advanced Drug Delivery Revenue and Market Share by Countries (2013-2018)
6.2 Germany Advanced Drug Delivery Sales and Growth Rate (2013-2018)
6.3 UK Advanced Drug Delivery Sales and Growth Rate (2013-2018)
6.4 France Advanced Drug Delivery Sales and Growth Rate (2013-2018)
6.5 Russia Advanced Drug Delivery Sales and Growth Rate (2013-2018)
6.6 Italy Advanced Drug Delivery Sales and Growth Rate (2013-2018)
7 Asia-Pacific Advanced Drug Delivery by Countries
7.1 Asia-Pacific Advanced Drug Delivery Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Advanced Drug Delivery Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Advanced Drug Delivery Revenue and Market Share by Countries (2013-2018)
7.2 China Advanced Drug Delivery Sales and Growth Rate (2013-2018)
7.3 Japan Advanced Drug Delivery Sales and Growth Rate (2013-2018)
7.4 Korea Advanced Drug Delivery Sales and Growth Rate (2013-2018)
7.5 India Advanced Drug Delivery Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Advanced Drug Delivery Sales and Growth Rate (2013-2018)
8 South America Advanced Drug Delivery by Countries
8.1 South America Advanced Drug Delivery Sales, Revenue and Market Share by Countries
8.1.1 South America Advanced Drug Delivery Sales and Market Share by Countries (2013-2018)
8.1.2 South America Advanced Drug Delivery Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Advanced Drug Delivery Sales and Growth Rate (2013-2018)
8.3 Argentina Advanced Drug Delivery Sales and Growth Rate (2013-2018)
8.4 Colombia Advanced Drug Delivery Sales and Growth Rate (2013-2018)
9 Middle East and Africa Advanced Drug Delivery by Countries
9.1 Middle East and Africa Advanced Drug Delivery Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Advanced Drug Delivery Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Advanced Drug Delivery Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Advanced Drug Delivery Sales and Growth Rate (2013-2018)
9.3 UAE Advanced Drug Delivery Sales and Growth Rate (2013-2018)
9.4 Egypt Advanced Drug Delivery Sales and Growth Rate (2013-2018)
9.5 Nigeria Advanced Drug Delivery Sales and Growth Rate (2013-2018)
9.6 South Africa Advanced Drug Delivery Sales and Growth Rate (2013-2018)
10 Global Advanced Drug Delivery Market Segment by Type
10.1 Global Advanced Drug Delivery Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Advanced Drug Delivery Sales and Market Share by Type (2013-2018)
10.1.2 Global Advanced Drug Delivery Revenue and Market Share by Type (2013-2018)
10.2 Polymeric Drug Delivery Sales Growth and Price
10.2.1 Global Polymeric Drug Delivery Sales Growth (2013-2018)
10.2.2 Global Polymeric Drug Delivery Price (2013-2018)
10.3 Implants & IUD's Sales Growth and Price
10.3.1 Global Implants & IUD's Sales Growth (2013-2018)
10.3.2 Global Implants & IUD's Price (2013-2018)
10.4 Sustained Release Sales Growth and Price
10.4.1 Global Sustained Release Sales Growth (2013-2018)
10.4.2 Global Sustained Release Price (2013-2018)
10.5 Targeted Drug Delivery Sales Growth and Price
10.5.1 Global Targeted Drug Delivery Sales Growth (2013-2018)
10.5.2 Global Targeted Drug Delivery Price (2013-2018)
10.6 Prodrugs Sales Growth and Price
10.6.1 Global Prodrugs Sales Growth (2013-2018)
10.6.2 Global Prodrugs Price (2013-2018)
11 Global Advanced Drug Delivery Market Segment by Application
11.1 Global Advanced Drug Delivery Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Diagnostic Centers Sales Growth (2013-2018)
11.4 Ambulatory Surgical Centers/Clinics Sales Growth (2013-2018)
11.5 Home Care Settings Sales Growth (2013-2018)
11.6 Other End Users Sales Growth (2013-2018)
12 Advanced Drug Delivery Market Forecast (2018-2023)
12.1 Global Advanced Drug Delivery Sales, Revenue and Growth Rate (2018-2023)
12.2 Advanced Drug Delivery Market Forecast by Regions (2018-2023)
12.2.1 North America Advanced Drug Delivery Market Forecast (2018-2023)
12.2.2 Europe Advanced Drug Delivery Market Forecast (2018-2023)
12.2.3 Asia-Pacific Advanced Drug Delivery Market Forecast (2018-2023)
12.2.4 South America Advanced Drug Delivery Market Forecast (2018-2023)
12.2.5 Middle East and Africa Advanced Drug Delivery Market Forecast (2018-2023)
12.3 Advanced Drug Delivery Market Forecast by Type (2018-2023)
12.3.1 Global Advanced Drug Delivery Sales Forecast by Type (2018-2023)
12.3.2 Global Advanced Drug Delivery Market Share Forecast by Type (2018-2023)
12.4 Advanced Drug Delivery Market Forecast by Application (2018-2023)
12.4.1 Global Advanced Drug Delivery Sales Forecast by Application (2018-2023)
12.4.2 Global Advanced Drug Delivery Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Advanced Drug Delivery Picture
Table Product Specifications of Advanced Drug Delivery
Figure Global Sales Market Share of Advanced Drug Delivery by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
